EP Biocomposites Q2 FY27 Results: Reports Loss of 43.40 Lakhs
RESULTS
▼ Concern Flagged
MEDIUM RISK
📅 Filed on BSE: 13 Nov 2026, 05:53 PM IST · BSE ID: bf852d88-d9dc-40e8-bc7e-1ff8faf96736
View Original BSE Filing (PDF)
💡
In Simple Terms
EP Biocomposites recorded a loss in the first half of FY27, with revenue declining compared to the previous year.
🤖 AI Summary
- EP Biocomposites Ltd reported a loss of 43.40 Lakhs for the half-year ended September 30, 2026.
- Revenue from operations was 295.38 Lakhs for Q2 FY27, a decrease from 407.48 Lakhs in Q2 FY26.
- This marks the first loss since the company's listing, as stated by management.
- Current orders in hand total 5.74 Crores, with an additional 7 Crores orders expected.
- Management anticipates stronger performance in the second half of the financial year.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Revenue from operations (Half Year Ended 30.09.2026)
295.38 Lakhs
-27.40%
Revenue from operations (Half Year Ended 30.09.2025)
407.48 Lakhs
Profit/ (Loss) for the period (Half Year Ended 30.09.2026)
-43.40 Lakhs
-580.44%
Profit/ (Loss) for the period (Half Year Ended 30.09.2025)
9.04 Lakhs
Basic EPS (Half Year Ended 30.09.2026)
-2.58
-577.78%
Basic EPS (Half Year Ended 30.09.2025)
0.54
Total Assets (As At 30-09-2026)
1,736.28 Lakhs
Total Assets (As At 31-03-2026)
1,873.14 Lakhs
🏢 How This Affects the Company
Revenue from operations for the half year ended September 30, 2026, decreased to 295.38 Lakhs from 407.48 Lakhs in the comparable prior period, indicating reduced sales volume or pricing.
The company reported a loss of 43.40 Lakhs for the period, a change from the profit of 9.04 Lakhs in the previous comparable half-year, impacting profitability and earnings.
The reported loss of 43.40 Lakhs for the half-year period introduces financial risk, as this is the first loss since the company's listing.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the reported net loss of 43.40 Lakhs for the half-year, which impacts the company's profitability.
🔍
Management Signal
Management's commentary signals reliance on a historical trend of stronger second-half performance to offset current period losses and achieve overall growth.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List - track these upcoming events
Q3 FY27 financial results — monitor if revenue and profit trends reverse as per management's commentary.
Updates on order book materialization — track if the expected 7 Crores worth of orders are secured.
Half Year Ended 31 March 2027 results — evaluate if the second half shows stronger performance.
MEDIUM RISK
The company reported its first loss since listing and a significant decline in revenue, indicating operational challenges.
💡 Investor Takeaway
EP Biocomposites Ltd reported a net loss of 43.40 Lakhs for the half-year ended September 30, 2026, compared to a profit of 9.04 Lakhs in Q2 FY26. Revenue from operations decreased to 295.38 Lakhs from 407.48 Lakhs. Management notes a historical trend of stronger second-half performance.
⚖️ Strengths & Concerns
✅ Positives
- Management noted current orders in hand worth 5.74 Crores, providing a confirmed revenue pipeline.
- Additional orders of 7 Crores are expected to materialize during the year, indicating potential for future revenue growth.
⚠️ Concerns
- EP Biocomposites reported a loss of 43.40 Lakhs for the half-year ended September 30, 2026, the first loss since listing.
- Revenue from operations decreased to 295.38 Lakhs for the half-year ended September 30, 2026, from 407.48 Lakhs in the prior comparable period.
📅 Company Track Record
EP Biocomposites Ltd was incorporated on December 15, 2020 (CIN: U28900GA2020PLC014240). The company was recently listed via an Initial Public Offer aggregating to 635.00 Lakhs, with net proceeds of 580.04 Lakhs. The company had a net profit after tax of 12.07 Lakhs for the first half of FY26 and 181.66 Lakhs for the second half of FY26.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was EP Biocomposites Ltd's net profit/loss for the half-year ended September 30, 2026?
EP Biocomposites Ltd reported a loss of 43.40 Lakhs for the half-year ended September 30, 2026, which is its first loss since listing.
How much revenue did EP Biocomposites Ltd generate in Q2 FY27?
EP Biocomposites Ltd generated Revenue from operations of 295.38 Lakhs for the half-year ended September 30, 2026 (Q2 FY27).
How does EP Biocomposites Ltd's Q2 FY27 revenue compare to the prior comparable period?
Revenue from operations for Q2 FY27 was 295.38 Lakhs, a decrease from 407.48 Lakhs reported for the half-year ended September 30, 2025.
What is EP Biocomposites Ltd's current order book position?
The company has present orders in hand amounting to 5.74 Crores, with another 7 Crores worth of orders expected to materialize during the year.
Questions based on this BSE filing only. For information purposes.